LMB-2 immunotoxin
Term · Oncology and biomedicine · MLC-T-ONC-004887
A toxic substance linked to an antibody that attaches to tumor cells and kills them.
A fusion protein consisting of the Fv portion of a monoclonal antibody attached to a 38-kDa fragment of the Pseudomonas exotoxin A (with amino acids 365-380 deleted). LMB-2 immunotoxin targets the interleukin 2 receptor (also known as IL-2R or CD25) which is expressed on activated normal T and B cells and macrophages and on the cells of various hematologic malignancies. The antibody attaches to the IL-2R on the cell membrane, facilitating the entry of the exotoxin. The exotoxin moiety induces caspase-mediated apoptosis of tumor cells via a mechanism involving mitochondrial damage; it also catalyzes the transfer of ADP ribose from nicotinamide adenine dinucleotide (NAD) to elongation factor-2 in eukaryotic cells, thereby inactivating elongation factor 2 and inhibiting protein synthesis.
| Identifier | MLC-T-ONC-004887 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | LMB-2 |
| Synonyms | Anti-Tac(Fv)-PE38; LMB-2 (anti-TAC(FV)-PE-38); humanized antiTac toxin| |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-004887",
"term": "LMB-2 immunotoxin",
"field": "Oncology and biomedicine",
"definitions": [
"A toxic substance linked to an antibody that attaches to tumor cells and kills them.",
"A fusion protein consisting of the Fv portion of a monoclonal antibody attached to a 38-kDa fragment of the Pseudomonas exotoxin A (with amino acids 365-380 deleted). LMB-2 immunotoxin targets the interleukin 2 receptor (also known as IL-2R or CD25) which is expressed on activated normal T and B cells and macrophages and on the cells of various hematologic malignancies. The antibody attaches to the IL-2R on the cell membrane, facilitating the entry of the exotoxin. The exotoxin moiety induces caspase-mediated apoptosis of tumor cells via a mechanism involving mitochondrial damage; it also catalyzes the transfer of ADP ribose from nicotinamide adenine dinucleotide (NAD) to elongation factor-2 in eukaryotic cells, thereby inactivating elongation factor 2 and inhibiting protein synthesis."
],
"abbreviation": "LMB-2",
"synonyms": [
"Anti-Tac(Fv)-PE38",
"LMB-2 (anti-TAC(FV)-PE-38)",
"humanized antiTac toxin|"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/lmb-2-immunotoxin/"
}
Record 10,237 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.